MARKETSPERPSLIVE115
Cash
Portfolio
TrendingElectionsPoliticsCultureSportsCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive115AccountSocial
Reminder: Weekly scheduled exchange maintenance will occur from 3-5 AM ET. Trading will be paused during this time.
Product
Kalshi ProPerpetual FuturesMarketsIncentive programInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQFee scheduleTrading hoursRegulatoryTrust Center
© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
Series Image
  1. Politics

When will CMS announce the addition of GLP-1 drugs for obesity to Part D?

Excludes the Medicare GLP-1 Bridge
Chance
Before Jan 1, 2027

11%

Before Jan 1, 2027

11%

Before Jan 1, 2028

29%

Before Jan 1, 2028

29%

Before Jan 20, 2029

49%

Before Jan 20, 2029

49%

When will CMS announce the addition of GLP-1 drugs for obesity to Part D?

Before Jan 1, 2027

Odds
6% chance
Max payout
Dec 31, 2026

$0

$21,449 vol